| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1001/JAMA.292.8.972 |
| P698 | PubMed publication ID | 15328330 |
| P50 | author | Ewa M Paleolog | Q123125987 |
| P2093 | author name string | Lorraine E Harry | |
| Branavan Sivakumar | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 972-977 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Modulating angiogenesis: more vs less | |
| P478 | volume | 292 |
| Q40308550 | A novel protein geranylgeranyltransferase-I inhibitor with high potency, selectivity, and cellular activity |
| Q53170593 | A potent anti-angiogenic factor, vasohibin-1, ameliorates experimental bronchiolitis obliterans. |
| Q38554714 | An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer. |
| Q34429244 | Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy |
| Q24241813 | Anti-angiogenic therapies for metastatic colorectal cancer |
| Q24239851 | Anti-angiogenic therapy for high grade glioma |
| Q24240185 | Anti-angiogenic therapy for high grade glioma |
| Q93336666 | Anti-angiogenic therapy for high-grade glioma |
| Q24243297 | Anti-angiogenic therapy for metastatic colorectal cancer |
| Q24193485 | Antiangiogenic therapy for high-grade glioma |
| Q60349665 | Association between bisphosphonates and jaw osteonecrosis: A study in Wistar rats |
| Q92249731 | Association between vascular endothelial growth factor receptor 2 rs11941492 C/T polymorphism and Chinese Han patients in rheumatoid arthritis |
| Q44635814 | Beta-adrenergic receptor regulation of growth factor protein levels in human choroidal endothelial cells |
| Q39700397 | Calvaria bone chamber--a new model for intravital assessment of osseous angiogenesis |
| Q37252297 | Characterization of vascular endothelial growth factor receptors on the endothelial cell surface during hypoxia using whole cell binding arrays |
| Q44016255 | Circulating angiopoietin and Tie-2 levels in systemic sclerosis |
| Q36809874 | Circulating endothelial progenitor cells as a link between synovial vascularity and cardiovascular mortality in rheumatoid arthritis |
| Q35894577 | Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs |
| Q36186023 | Custom design of the cardiac microenvironment with biomaterials |
| Q35208442 | Differentiated thyroid cancer with liver metastases: lessons learned from managing a series of 14 patients |
| Q53526418 | Effect of soft-tissue attachment on tibial fracture healing in rats. |
| Q33873733 | Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity |
| Q41842959 | Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis |
| Q34346264 | Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair |
| Q24813100 | It's all in the blood: circulating endothelial progenitor cells link synovial vascularity with cardiovascular mortality in rheumatoid arthritis? |
| Q57781430 | Microvascular response to calcium phosphate bone substitutes: an intravital microscopy analysis |
| Q55564375 | Molecular Therapies in Thyroid Cancer. |
| Q36955347 | Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis |
| Q36742274 | Pathophysiology of tumor neovascularization |
| Q34345914 | Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization. |
| Q38406281 | Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction |
| Q36257966 | Protective effects of angiotensin II interruption: evidence for antiinflammatory actions |
| Q35607267 | Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis |
| Q36101506 | Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis |
| Q42727110 | Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome |
| Q34419120 | Role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis |
| Q35906866 | Sensing the cardiac environment: exploiting cues for regeneration |
| Q91909312 | Tendon healing in the context of complex fractures |
| Q38182175 | The potential role of angiogenic factors in rheumatoid arthritis |
| Q36891571 | Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation |
| Q58691977 | What Have We Learned about the Pathogenesis of Rheumatoid Arthritis from TNF-Targeted Therapy? |
| Q91969118 | ZYZ-803, a novel hydrogen sulfide-nitric oxide conjugated donor, promotes angiogenesis via cross-talk between STAT3 and CaMKII |
Search more.